Browse > Article
http://dx.doi.org/10.22246/jikm.2016.37.4.631

Reliability and Validity Analysis of an Instrument for Pattern Identification and Evaluation in Chemotherapy-Induced Peripheral Neuropathy  

Park, Ji-hye (East West Cancer Center, Dunsan Korean Medicine Hospital of Dae-Jeon University)
Jung, In-chul (Dept. of Oriental Neuropsychiatry, College of Korean Medicine, Dae-Jeon University)
Lee, Seo-hyun (Dept. of Statistics, Chung-Nam National University)
Lee, Suk-hoon (Dept. of Statistics, Chung-Nam National University)
Choi, Seok-cheol (Dept. of Gynecologic Oncology, Yuseong Sun Medical Center)
Yoo, Hwa-seung (East West Cancer Center, Dunsan Korean Medicine Hospital of Dae-Jeon University)
Publication Information
The Journal of Internal Korean Medicine / v.37, no.4, 2016 , pp. 631-644 More about this Journal
Abstract
Objectives: The purpose of this study was to evaluate the reliability and validity of an instrument for pattern identification and evaluation in chemotherapy-induced peripheral neuropathy (CIPN).Methods: The study consisted of 66 patients with CIPN (visual analog scale ≥30 mm, Eastern Cooperative Oncology Group ≤2). The test-retest reliability of the instrument for pattern identification and evaluation in CIPN was tested twice with the same patients in one week.Results: Pearson’s coefficient test-retest reliability of the instrument was 0.601-0.777. The internal reliability of each part was 0.619-0.811. To confirm the validity of the instrument for pattern identification and evaluation for CIPN, the correlation between the score for each identification pattern and that of other CIPN instruments was analyzed. The results revealed a positive correlation between the Functional Assessment of Cancer Therapy-General and CIPN-20.Conclusion: The reliability of the instrument for pattern identification and evaluation in CIPN was moderate, and the validity analysis revealed a positive correlation.
Keywords
chemotherapy induced peripheral neuropathy; reliability; validity; instrument on pattern identifications and evaluation;
Citations & Related Records
Times Cited By KSCI : 8  (Citation Analysis)
연도 인용수 순위
1 Choie MH, Jeong IS, Jeong TY, Kim KS, Yoo HS. Effects of reflexology foot massage to improve quality of life and reduce anxiety for hospitalized cancer patients undergoing chemotherapy or radioisotope therapy. J Korean Trad Oncol 2009;14:61-74.
2 Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008;13(1):27-46.   DOI
3 Smith EM, Beck SL, Cohen J. The total neuropathy score:a tool for measuring chemotherapy induced peripheral neuropathy. Oncol Nurs Forum 2008;35:96-102.   DOI
4 Wickhan R. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice. Clin J Oncol Nurs 2007;11:361-76.   DOI
5 Kwak MK, Kim EJ, Lee ER, Kwon IG, Hwang MS. Characteristics and quality of life in patients with chemotherapy-induced peripheral neuropathy. J Korean Oncol Nurs 2010;10(2):231-9.   DOI
6 Housheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33;15-49.
7 Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990;8:147-59.   DOI
8 Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.   DOI
9 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.   DOI
10 Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, et al. Multi-center assessment of he Total Neuropathy Score for chemotherapy-induced peripheral eurotoxicity. J Peripher Nerv Syst 2006;11:135-41.   DOI
11 Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, et al. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. Eur J Cancer 1997;33(9):1393-9.   DOI
12 du Bois A, Schlaich M, Luck HJ, Mollenkopf A, Wechsel U, Rauchholz M, et al. Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care Cancer 1999;7(5):354-61.   DOI
13 Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM, et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol 1997;35(1):47-53.   DOI
14 Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nurs 2011;34(4):E10-20.   DOI
15 Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994;35(3):304-11.   DOI
16 Kim JH, Choi KS, Kim TW, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Asian Oncology Nursing 2011;11(3):254-62.
17 Kim HY, Kang JH, Youn HJ, So HS, Song CE, Chae SY, et al. Reliability and validty of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to assess chemotherapy-induced peripheral neuropathy. J Korean Acad Nurs 2014;44(6):735-42.   DOI
18 Park JH, Jung IC, Lee SH, Lee JS, Bae KR, Cho CK, et al. Preliminary Study to Develop an Instrument for Pattern Identification and Evaluation for Chemotherapy-induced Peripheral Neuropathy (CIPN). The Journal of Korean Oriental Internal Medicine 2016;37(1):77-89.   DOI
19 Lee HS, Choi WC, Yun SY, Kang WC, Jung IC. Reliability and Validity Analysis of the Instrument of Oriental Medical Evaluation for Hwa-Byung. The Korean Society of Oriental Neuropsychiatry 2014;25(4):351-8.   DOI
20 Choi WC, Lee HS, Seo BN, Kang WC, Jung IC. A Study to Assess the Reliability and Improvement of the Instrument of Pattern Identification for Jing Ji and Zheng Chong. The Korean Society of Oriental Neuropsychiatry 2014;25(4):371-82.   DOI
21 National Statistical Office, Korean Statistical Information Service, 2014, available from: URL:http://www.kosis.kr/. Accessed June 10. 2016.
22 Nurgalieva Z, Xia R, Liu C-C, Burau K, Hardy D, Du XL. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. Am J Ther 2010;17(2):148-58.   DOI
23 Available from: URL: http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040105000000. Accessed June 10. 2016.
24 Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 2007;11(6):901-13.   DOI
25 Kim IY. Review article: Management of peripheral neuropathy for cancer patients. Kor Clin Oncol 2011;7(1):11-22.   DOI
26 Muthuraman A, Singh N. Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats. Journal of natural medicines 2011;65(3-4):480-7.   DOI
27 Abad A, Nouri M, Gharjanie A, Tavakoli F. Effect of Matricaria chamomilla hydroalcoholic extract on Cisplatin-induced neuropathy in mice. Chinese Journal of Natural Medicine 2011;9(2):126-31.   DOI
28 Xu F, Xu S, Wang L, Chen C, Zhou X, Lu Y, et al. Antinociceptive efficacy of verticinone in murine models of inflammatory pain and paclitaxel induced neuropathic pain. Biological & pharmaceutical bulletin 2011;34(9):1377-82.   DOI
29 Schroder S, Beckmann K, Franconi G, Meyer-Hamme G, Friedemann T, Greten HJ, et al. Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evidence-based complementary and alternative medicine 2013:423713.
30 Nishioka M, Shimada M, Kurita N, Iwata T, Morimoto S, Yoshikawa K, et al. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. International journal of clinical oncology 2011;16(4):322-7.   DOI
31 Kono T, Mamiya N, Chisato N, Ebisawa Y, Yamazaki H, Watari J, et al. Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evidence-based complementary and alternative medicine 2011:418481.
32 Kaku H, Kumagai S, Onoue H, Takada A, Shoji T, Miura F, et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study. Experimental and therapeutic medicine 2012;3(1):60-5.   DOI
33 Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain research and treatment 2011:920807.
34 Donald GK, Tobin I, Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupuncture in medicine : journal of the British Medical Acupuncture Society 2011;29(3):230-3.   DOI
35 Schroeder S, Meyer-Hamme G, Epplee S. Acupuncture for chemotherapy-induced peripheral neuropathy(CIPN): a pilot study using neurography. Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012;30(1):4-7.   DOI
36 Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evidence-based complementary and alternative medicine 2013:349653.
37 Seong TJ. Validity and Reliability. Seoul: Hakjisa Publisher; 2007, p. 36-9, 83-8.
38 Lee JH, Park HL, Lee HY, Cho MK, Hong MN, Han CW, et al. Case Report of Chemotherapy Induced Peripheral Neuropathy Treated with Korean Medicine. Journal of physiology & pathology in Korean Medicine 2014;28(5):565-70.
39 Chung SK. The Literatural Study on Arthralgia Syndrome. Journal of Korean oriental medical society 1995;16:(1):9-20.